Vanguard Group’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266M | Sell |
9,256,132
-55,468
| -0.6% | -$1.6M | ﹤0.01% | 1366 |
|
|
2025
Q1 | $312M | Buy |
9,311,600
+222,209
| +2% | +$7.45M | 0.01% | 1253 |
|
|
2024
Q4 | $465M | Buy |
9,089,391
+2,801,736
| +45% | +$143M | 0.01% | 1081 |
|
|
2024
Q3 | $321M | Buy |
6,287,655
+1,773,177
| +39% | +$90.6M | 0.01% | 1290 |
|
|
2024
Q2 | $202M | Buy |
4,514,478
+939,402
| +26% | +$42.1M | ﹤0.01% | 1491 |
|
|
2024
Q1 | $167M | Buy |
3,575,076
+72,624
| +2% | +$3.4M | ﹤0.01% | 1616 |
|
|
2023
Q4 | $125M | Buy |
3,502,452
+95,417
| +3% | +$3.39M | ﹤0.01% | 1744 |
|
|
2023
Q3 | $101M | Buy |
3,407,035
+674,301
| +25% | +$20.1M | ﹤0.01% | 1806 |
|
|
2023
Q2 | $49.2M | Buy |
2,732,734
+39,672
| +1% | +$715K | ﹤0.01% | 2190 |
|
|
2023
Q1 | $43.3M | Buy |
2,693,062
+306,675
| +13% | +$4.93M | ﹤0.01% | 2239 |
|
|
2022
Q4 | $43.7M | Buy |
2,386,387
+29,740
| +1% | +$544K | ﹤0.01% | 2249 |
|
|
2022
Q3 | $46.3M | Sell |
2,356,647
-87,867
| -4% | -$1.73M | ﹤0.01% | 2223 |
|
|
2022
Q2 | $45.6M | Buy |
2,444,514
+345,201
| +16% | +$6.44M | ﹤0.01% | 2241 |
|
|
2022
Q1 | $46.1M | Buy |
2,099,313
+2,415
| +0.1% | +$53K | ﹤0.01% | 2342 |
|
|
2021
Q4 | $59.6M | Buy |
2,096,898
+421,017
| +25% | +$12M | ﹤0.01% | 2254 |
|
|
2021
Q3 | $35.3M | Buy |
1,675,881
+173,044
| +12% | +$3.64M | ﹤0.01% | 2551 |
|
|
2021
Q2 | $28.3M | Buy |
1,502,837
+338,920
| +29% | +$6.39M | ﹤0.01% | 2661 |
|
|
2021
Q1 | $17.8M | Buy |
1,163,917
+11,659
| +1% | +$178K | ﹤0.01% | 2847 |
|
|
2020
Q4 | $16.3M | Buy |
1,152,258
+71,160
| +7% | +$1M | ﹤0.01% | 2740 |
|
|
2020
Q3 | $16.9M | Buy |
1,081,098
+62
| +0% | +$971 | ﹤0.01% | 2541 |
|
|
2020
Q2 | $18.9M | Buy |
1,081,036
+572,819
| +113% | +$10M | ﹤0.01% | 2455 |
|
|
2020
Q1 | $7.47M | Buy |
508,217
+4,216
| +0.8% | +$62K | ﹤0.01% | 2757 |
|
|
2019
Q4 | $12.6M | Sell |
504,001
-100
| -0% | -$2.51K | ﹤0.01% | 2743 |
|
|
2019
Q3 | $7.58M | Sell |
504,101
-438
| -0.1% | -$6.59K | ﹤0.01% | 2963 |
|
|
2019
Q2 | $12.6M | Buy |
504,539
+52,327
| +12% | +$1.31M | ﹤0.01% | 2727 |
|
|
2019
Q1 | $10.3M | Buy |
452,212
+179,489
| +66% | +$4.09M | ﹤0.01% | 2809 |
|
|
2018
Q4 | $8.18M | Buy |
272,723
+24,800
| +10% | +$744K | ﹤0.01% | 2863 |
|
|
2018
Q3 | $7.1M | Buy |
+247,923
| New | +$7.1M | ﹤0.01% | 3098 |
|